Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation

NCT02037373 · clinicaltrials.gov ↗

TERMINATED

Status

43

Enrollment

INDUSTRY

Sponsor class

Stopped FDA released requirement to complete study

Conditions

Coagulopathy
Endstage Liver Disease

Interventions

BIOLOGICAL: Octaplas™
BIOLOGICAL: Plasma

Sponsor

Octapharma